FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Mississippi man accused of killing six in shooting spree pleads not guilty

Rep Ro Khanna demands prosecution of ICE agent in Minneapolis fatal shooting

Jack Smith to testify next week at a public House Judiciary Committee hearing

Nonprofit revenue totals surge amid growing scrutiny after major fraud cases

Trump imposes 25% tariff on any country doing business with Iran

‘Disturbance’ at Georgia Prison Leaves 3 Inmates Dead, a Dozen More Injured

Trump rips congestion pricing, calls for immediate end: ‘A disaster for New York’

Minnesota sues Trump admin over sweeping immigration raids in Twin Cities

Data Is In: Homes Becoming More Affordable as Trump Admin Removes Illegal Aliens

Tyler Robinson prosecutors say Charlie Kirk shooting texts show confusion, not bias, to rebut conflict claim

Ex-congressional IT aide accused of stealing 240 government phones and selling them at pawn shop

Senate advances $174B package as Minnesota ICE shooting fuels DHS funding fight

Man Arrested After Attack on School Bus Seriously Injures 8-Year-Old Girl

Jeffries says DHS Secretary Noem ‘should be run out of town’ amid ICE shooting backlash

Iran’s crown prince calls for renewed nationwide protests despite killings: ‘This is a war’

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”